node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
ADIPOQ | ADIPOR2 | ENSSSCP00000046998 | ENSSSCP00000000805 | C1q domain-containing protein. | Adiponectin receptor protein 2 isoform X1. | 0.999 |
ADIPOQ | APPL1 | ENSSSCP00000046998 | ENSSSCP00000038724 | C1q domain-containing protein. | Adaptor protein phosphotyrosine interaction PH domain and leucine zipper containing 1. | 0.658 |
ADIPOQ | INS | ENSSSCP00000046998 | ENSSSCP00000044635 | C1q domain-containing protein. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.915 |
ADIPOQ | LEP | ENSSSCP00000046998 | ENSSSCP00000056831 | C1q domain-containing protein. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.971 |
ADIPOQ | NAMPT | ENSSSCP00000046998 | ENSSSCP00000043109 | C1q domain-containing protein. | Nicotinamide phosphoribosyltransferase; Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock fun [...] | 0.807 |
ADIPOQ | PPARA | ENSSSCP00000046998 | ENSSSCP00000000007 | C1q domain-containing protein. | Uncharacterized protein. | 0.775 |
ADIPOQ | RETN | ENSSSCP00000046998 | ENSSSCP00000029297 | C1q domain-containing protein. | Resistin. | 0.934 |
ADIPOQ | RETNLB | ENSSSCP00000046998 | ENSSSCP00000012720 | C1q domain-containing protein. | Resistin-like beta protein. | 0.904 |
ADIPOR2 | ADIPOQ | ENSSSCP00000000805 | ENSSSCP00000046998 | Adiponectin receptor protein 2 isoform X1. | C1q domain-containing protein. | 0.999 |
ADIPOR2 | APPL1 | ENSSSCP00000000805 | ENSSSCP00000038724 | Adiponectin receptor protein 2 isoform X1. | Adaptor protein phosphotyrosine interaction PH domain and leucine zipper containing 1. | 0.985 |
ADIPOR2 | INS | ENSSSCP00000000805 | ENSSSCP00000044635 | Adiponectin receptor protein 2 isoform X1. | Insulin A chain; Insulin decreases blood glucose concentration. It increases cell permeability to monosaccharides, amino acids and fatty acids. It accelerates glycolysis, the pentose phosphate cycle, and glycogen synthesis in liver. | 0.659 |
ADIPOR2 | LEP | ENSSSCP00000000805 | ENSSSCP00000056831 | Adiponectin receptor protein 2 isoform X1. | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] | 0.801 |
ADIPOR2 | NAMPT | ENSSSCP00000000805 | ENSSSCP00000043109 | Adiponectin receptor protein 2 isoform X1. | Nicotinamide phosphoribosyltransferase; Catalyzes the condensation of nicotinamide with 5- phosphoribosyl-1-pyrophosphate to yield nicotinamide mononucleotide, an intermediate in the biosynthesis of NAD. It is the rate limiting component in the mammalian NAD biosynthesis pathway. The secreted form behaves both as a cytokine with immunomodulating properties and an adipokine with anti-diabetic properties, it has no enzymatic activity, partly because of lack of activation by ATP, which has a low level in extracellular space and plasma. Plays a role in the modulation of circadian clock fun [...] | 0.678 |
ADIPOR2 | PPARA | ENSSSCP00000000805 | ENSSSCP00000000007 | Adiponectin receptor protein 2 isoform X1. | Uncharacterized protein. | 0.687 |
ADIPOR2 | RETN | ENSSSCP00000000805 | ENSSSCP00000029297 | Adiponectin receptor protein 2 isoform X1. | Resistin. | 0.724 |
ADIPOR2 | RETNLB | ENSSSCP00000000805 | ENSSSCP00000012720 | Adiponectin receptor protein 2 isoform X1. | Resistin-like beta protein. | 0.712 |
ADIPOR2 | TLCD1 | ENSSSCP00000000805 | ENSSSCP00000036434 | Adiponectin receptor protein 2 isoform X1. | TLC domain containing 1. | 0.649 |
ADIPOR2 | TLCD2 | ENSSSCP00000000805 | ENSSSCP00000053116 | Adiponectin receptor protein 2 isoform X1. | TLC domain containing 2. | 0.613 |
APPL1 | ADIPOQ | ENSSSCP00000038724 | ENSSSCP00000046998 | Adaptor protein phosphotyrosine interaction PH domain and leucine zipper containing 1. | C1q domain-containing protein. | 0.658 |
APPL1 | ADIPOR2 | ENSSSCP00000038724 | ENSSSCP00000000805 | Adaptor protein phosphotyrosine interaction PH domain and leucine zipper containing 1. | Adiponectin receptor protein 2 isoform X1. | 0.985 |